Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-27 @ 12:20 AM
Study NCT ID:
NCT04908566
Status:
RECRUITING
Last Update Posted:
2021-06-01
First Post:
2021-04-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-27
First Submit QC Date:
None
Study First Post Date:
2021-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-27
Last Update Post Date:
2021-06-01
Last Update Post Date Type:
ACTUAL